Birutė Brasiūnienė

572 total citations
27 papers, 126 citations indexed

About

Birutė Brasiūnienė is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Birutė Brasiūnienė has authored 27 papers receiving a total of 126 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 8 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Birutė Brasiūnienė's work include Pancreatic and Hepatic Oncology Research (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Ovarian cancer diagnosis and treatment (4 papers). Birutė Brasiūnienė is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Ovarian cancer diagnosis and treatment (4 papers). Birutė Brasiūnienė collaborates with scholars based in Lithuania, Belgium and Spain. Birutė Brasiūnienė's co-authors include Elona Juozaitytė, Laimonas Griškevičius, Kęstutis Strupas, Ieva Vincerževskienė, Arturas Inčiūra, Aušrinė Barakauskienė, Giedrius Barauskas, Pablo Maroto, Francesco Massari and Ernest Choy and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Birutė Brasiūnienė

25 papers receiving 123 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Birutė Brasiūnienė Lithuania 8 71 38 25 23 17 27 126
Naïri Tchrakian Canada 7 50 0.7× 27 0.7× 33 1.3× 36 1.6× 20 1.2× 12 145
Pierre-Emmanuel Brachet France 6 47 0.7× 39 1.0× 32 1.3× 17 0.7× 35 2.1× 18 118
Thais Maloberti Italy 6 62 0.9× 31 0.8× 32 1.3× 54 2.3× 18 1.1× 40 164
Erik Asmus United States 6 100 1.4× 41 1.1× 17 0.7× 39 1.7× 43 2.5× 9 179
Petra Jankowska United Kingdom 4 34 0.5× 24 0.6× 31 1.2× 35 1.5× 21 1.2× 6 141
Jana Drozenová Czechia 8 66 0.9× 34 0.9× 23 0.9× 49 2.1× 45 2.6× 29 202
Stefano Panni Italy 7 141 2.0× 61 1.6× 32 1.3× 15 0.7× 4 0.2× 23 182
Qingxia Fan China 7 112 1.6× 49 1.3× 37 1.5× 20 0.9× 5 0.3× 17 156
Sheik Emambux France 8 105 1.5× 77 2.0× 32 1.3× 36 1.6× 10 0.6× 13 174
E. Razis Greece 5 27 0.4× 24 0.6× 26 1.0× 13 0.6× 19 1.1× 20 76

Countries citing papers authored by Birutė Brasiūnienė

Since Specialization
Citations

This map shows the geographic impact of Birutė Brasiūnienė's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birutė Brasiūnienė with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birutė Brasiūnienė more than expected).

Fields of papers citing papers by Birutė Brasiūnienė

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birutė Brasiūnienė. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birutė Brasiūnienė. The network helps show where Birutė Brasiūnienė may publish in the future.

Co-authorship network of co-authors of Birutė Brasiūnienė

This figure shows the co-authorship network connecting the top 25 collaborators of Birutė Brasiūnienė. A scholar is included among the top collaborators of Birutė Brasiūnienė based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birutė Brasiūnienė. Birutė Brasiūnienė is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Tagliamento, Marco, Marie Morfouace, Júlio Oliveira, et al.. (2024). EORTC-SPECTA Arcagen study, comprehensive genomic profiling and treatment adaptation of rare thoracic cancers. npj Precision Oncology. 8(1). 37–37. 6 indexed citations
4.
Everatt, Rūta, et al.. (2024). Evaluation of antihypertensive medications use and survival in patients with ovarian cancer: a population-based retrospective cohort study. BMC Women s Health. 24(1). 155–155. 1 indexed citations
5.
Halteren, Henk K. van, Jaafar Bennouna, Birutė Brasiūnienė, et al.. (2023). Twelve ESMO Congress 2022 breakthroughs: practicing oncologists’ perceptions and potential application on presented data. ESMO Open. 8(1). 100773–100773. 2 indexed citations
6.
7.
8.
9.
Dabkevičienė, Daiva, Rasa Sabaliauskaitė, Violeta Jonušienė, et al.. (2022). Components of NOTCH Signaling for Uterine Cancer Patients’ Prognosis. Journal of Oncology. 2022. 1–8. 3 indexed citations
10.
Aidietienė, Sigita, et al.. (2022). Development of a Cardio-Oncology Service in Lithuania: Prediction, Prevention, Monitoring and Treatment of Cancer Treatment-Induced Cardiotoxicity. Journal of Cardiovascular Development and Disease. 9(5). 134–134. 1 indexed citations
11.
Besusparis, Justinas, et al.. (2020). Recurrent Germline BRCA2 Gene Mutation in Lithuanian Family. Medicina. 56(3). 119–119. 1 indexed citations
12.
Loriot, Yohann, Cora N. Sternberg, Daniel Castellano, et al.. (2020). Safety and efficacy of atezolizumab in patients with autoimmune disease: Subgroup analysis of the SAUL study in locally advanced/metastatic urinary tract carcinoma. European Journal of Cancer. 138. 202–211. 21 indexed citations
13.
Gineikienė, Eglė, et al.. (2012). Clear cell sarcoma expressing a novel chimerical transcript EWSR1 exon 7/ATF1 exon 6. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 461(3). 339–343. 8 indexed citations
14.
Janavičius, Ramūnas, et al.. (2011). Apparently “BRCA-Related” Breast and Ovarian Cancer Patient With Germline TP53 Mutation. The Breast Journal. 17(4). 409–415. 8 indexed citations
15.
Brasiūnienė, Birutė, et al.. (2011). Combined treatment of uveal melanoma liver metastases. European journal of medical research. 16(2). 71–71. 10 indexed citations
16.
Brasiūnienė, Birutė & Elona Juozaitytė. (2007). The effect of combined treatment methods on survival and toxicity in patients with pancreatic cancer. Medicina. 43(9). 716–716. 7 indexed citations
17.
Brasiūnienė, Birutė, et al.. (2006). Kasos vėžio kompleksinio gydymo įtaka ligonių gyvenimo kokybei. Laba (Lietuvos akademinių bibliotekų direktorių asociacija). 42(10). 817–822.
18.
Brasiūnienė, Birutė, et al.. (2004). Evaluation of clinical factors and treatment results in patients with advanced pancreatic cancer.. PubMed. 40(11). 1074–80. 3 indexed citations
19.
Brasiūnienė, Birutė, et al.. (2003). Šiuolaikinė kasos vėžio chemoterapija. Medicina-buenos Aires. 39(10). 1016–1025. 1 indexed citations
20.
Brasiūnienė, Birutė, et al.. (2003). [The update on pancreatic cancer chemotherapy].. PubMed. 39(10). 1016–25. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naïri Tchrakian Breakdown of academic impact, for papers by Pierre-Emmanuel Brachet Breakdown of academic impact, for papers by Thais Maloberti Breakdown of academic impact, for papers by Erik Asmus Breakdown of academic impact, for papers by Petra Jankowska Breakdown of academic impact, for papers by Jana Drozenová Breakdown of academic impact, for papers by Stefano Panni Breakdown of academic impact, for papers by Qingxia Fan Breakdown of academic impact, for papers by Sheik Emambux Breakdown of academic impact, for papers by E. Razis
Rankless by CCL
2026